Aureus Asset Management’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,511
| Closed | -$16.2K | – | 213 |
|
|
2023
Q4 | $16.2K | Hold |
1,511
| – | – | ﹤0.01% | 196 |
|
|
2023
Q3 | $9.06K | Hold |
1,511
| – | – | ﹤0.01% | 193 |
|
|
2023
Q2 | $10.4K | Hold |
1,511
| – | – | ﹤0.01% | 185 |
|
|
2023
Q1 | $23.7K | Hold |
1,511
| – | – | ﹤0.01% | 180 |
|
|
2022
Q4 | $30.2K | Hold |
1,511
| – | – | ﹤0.01% | 174 |
|
|
2022
Q3 | $27K | Hold |
1,511
| – | – | ﹤0.01% | 166 |
|
|
2022
Q2 | $34K | Hold |
1,511
| – | – | ﹤0.01% | 183 |
|
|
2022
Q1 | $42K | Hold |
1,511
| – | – | ﹤0.01% | 213 |
|
|
2021
Q4 | $69K | Hold |
1,511
| – | – | ﹤0.01% | 206 |
|
|
2021
Q3 | $126K | Hold |
1,511
| – | – | 0.01% | 205 |
|
|
2021
Q2 | $144K | Hold |
1,511
| – | – | 0.01% | 225 |
|
|
2021
Q1 | $251K | Sell |
1,511
-2,000
| -57% | -$332K | 0.02% | 154 |
|
|
2020
Q4 | $344K | Hold |
3,511
| – | – | 0.03% | 144 |
|
|
2020
Q3 | $119K | Hold |
3,511
| – | – | 0.01% | 173 |
|
|
2020
Q2 | $199K | Hold |
3,511
| – | – | 0.02% | 164 |
|
|
2020
Q1 | $206K | Hold |
3,511
| – | – | 0.03% | 141 |
|
|
2019
Q4 | $277K | Hold |
3,511
| – | – | 0.03% | 152 |
|
|
2019
Q3 | $351K | Hold |
3,511
| – | – | 0.04% | 125 |
|
|
2019
Q2 | $468K | Buy |
+3,511
| New | +$468K | 0.06% | 111 |
|